Relmada Therapeutics, Inc. (RLMD)
6.39
+0.05
(+0.79%)
USD |
NASDAQ |
May 19, 10:11
Relmada Therapeutics Price : 6.39 for May 19, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Theravance Biopharma, Inc. | 16.17 |
| AN2 Therapeutics, Inc. | 4.41 |
| Corcept Therapeutics, Inc. | 55.00 |
| Assertio Holdings, Inc. | 23.42 |
| Johnson & Johnson | 229.50 |
Price Related Metrics
| Price to Book Value | 3.064 |
| Earnings Yield | -17.41% |
| Market Cap | 670.25M |